Decisión del Panel Administrativo nº D2021-2683 of WIPO Arbitration and Mediation Center, October 19, 2021 (case CoverMyMeds LLC v. 蒋黎 (Leed Johnny, Johnny))
| Resolution Date | October 19, 2021 |
| Issuing Organization | WIPO Arbitration and Mediation Center |
| Decision | Transfer |
| Dominio | Generic Domains |
The Complainant is CoverMyMeds LLC, United States of America (“United States”), represented internally.
The Respondent is 蒋黎 (Leed Johnny, Johnny), China.
The disputed domain names [cobermymeds.com], [cocermymeds.com], and [covermymefs.com] are registered with Alibaba Cloud Computing (Beijing) Co., Ltd. (the “Registrar”).
The Complaint in English was filed with the WIPO Arbitration and Mediation Center (the “Center”) on August 17, 2021. On August 17, 2021, the Center transmitted by email to the Registrar a request for registrar verification in connection with the disputed domain names. On August 19, 2021, the Registrar transmitted by email to the Center its verification response disclosing registrant and contact information for the disputed domain names which differed from the named Respondent and contact information in the Complaint. The Center sent an email communication to the Complainant on August 23, 2021, providing the registrant and contact information disclosed by the Registrar, and inviting the Complainant to submit an amendment to the Complaint. The Complainant filed an amendment to the Complaint in English on August 28, 2021, and an amended Complaint in English on September 2, 2021.
On August 23, 2021, the Center transmitted an email communication to the Parties in English and Chinese regarding the language of the administrative proceeding. On August 26, 2021, the Complainant confirmed its request that English be the language of the administrative proceeding. The Respondent did not comment on the language of the administrative proceeding.
The Center verified that the Complaint together with the amendment to the Complaint and amended Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”).
In accordance with the Rules, paragraphs 2 and 4, the Center formally notified the Respondent in English and Chinese of the Complaint, and the proceedings commenced on September 6, 2021. In accordance with the Rules, paragraph 5, the due date for Response was September 26, 2021. The Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on September 29, 2021.
The Center appointed Francine Tan as the sole panelist in this matter on October 13, 2021. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7.
The Complainant, CoverMyMeds LLC, states that it is a subsidiary of McKesson Corporation (“McKesson”) which is one of the oldest and largest healthcare companies in the United States. McKesson was founded in 1833, has over 76,000 employees, and provides a wide range of innovative healthcare distribution solutions to business and patients, including in the areas of pharmaceuticals, medicine and surgery, and specialty health. McKesson's headquarters are in Irving, Texas, and it maintains offices and facilities throughout the United States and worldwide.
The Complainant states that McKesson is ranked 7th on the FORTUNE 500, with more than USD 200 billion in annual revenue. McKesson delivers vital medicines, medical supplies, and healthcare information...
To continue reading
Request your trial